The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Management of Diabetic Retinopathy: A Systematic Review
Abstract
CONTEXT: Diabetic retinopathy (DR) is the leading cause of blindness in the working-aged population in the United States. There are many new interventions for DR, but evidence to support their use is uncertain. OBJECTIVE: To review the best evidence for primary and secondary intervention in the management of DR, including diabetic macular edema. EVIDENCE ACQUISITION: Systematic review of all English-language articles, retrieved using a keyword search of MEDLINE (1966 through May 2007), EMBASE, Cochrane Collaboration, the Association for Research in Vision and Ophthalmology database, and the National Institutes of Health Clinical Trials Database, and followed by manual searches of reference lists of selected major review articles. All English-language randomized controlled trials (RCTs) with more than 12 months of follow-up and meta-analyses were included. Delphi consensus criteria were used to identify well-conducted studies. EVIDENCE SYNTHESIS: Forty-four studies (including 3 meta-analyses) met the inclusion criteria. Tight glycemic and blood pressure control reduces the incidence and progression of DR. Pan-retinal laser photocoagulation reduces the risk of moderate and severe visual loss by 50% in patients with severe nonproliferative and proliferative retinopathy. Focal laser photocoagulation reduces the risk of moderate visual loss by 50% to 70% in eyes with macular edema. Early vitrectomy improves visual recovery in patients with proliferative retinopathy and severe vitreous hemorrhage. Intravitreal injections of steroids may be considered in eyes with persistent loss of vision when conventional treatment has failed. There is insufficient evidence for the efficacy or safety of lipid-lowering therapy, medical interventions, or antivascular endothelial growth factors on the incidence or progression of DR. CONCLUSIONS: Tight glycemic and blood pressure control remains the cornerstone in the primary prevention of DR. Pan-retinal and focal retinal laser photocoagulation reduces the risk of visual loss in patients with severe DR and macular edema, respectively. There is currently insufficient evidence to recommend routine use of other treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00131-0 · Cited by 2,379
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Klein, R., Klein, B. E. K., Moss, S. E., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32011-1 · Cited by 1,340
Reichard, P., Nilsson, B.-Y., & Rosenqvist, U. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290502 · Cited by 1,202
Intravitreal triamcinolone for refractory diabetic macular edema
Martidis, A., Duker, J. S., Greenberg, P. B., Rogers, A. H., Puliafito, C. A., Reichel, E., & Baumal, C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00975-2 · Cited by 1,032
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Schrier, R. W., Estacio, R. O., Esler, A., & Mehler, P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00213.x · Cited by 851
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Avery, R. L., Pearlman, J., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., Giust, M. J., Wendel, R., & Patel, A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.064 · Cited by 799
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
Chaturvedi, N., Sjolie, A.-K., Stephenson, J. M., Abrahamian, H., Keipes, M., Castellarin, A., Rogulja-Pepeonik, Z., & Fuller, J. H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06209-0 · Cited by 743
The Wisconsin epidemiologic study of diabetic retinopathy: XVII
Klein, R., Klein, B. E. K., Moss, S. E., & Cruickshanks, K. J. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)91020-x · Cited by 730
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
Shichiri, M., Kishikawa, H., Ohkubo, Y., & Wake, N. (2000) · PubMed · Cited by 727
Chew, E. Y. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140281004 · Cited by 713
(2000) · PubMed · Cited by 691
Diabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, F. M. A., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 684
Self-citationPatz, A., Fine, S., Finkelstein, D., Prout, T., Aiello, L., Bradley, R., Briones, J. C., Myers, F., Bresnick, G., de Venecia, G., et al. (1978) · Ophthalmology · doi:10.1016/s0161-6420(78)35693-1 · Cited by 652
Wong, T., & Mitchell, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60198-6 · Cited by 585
Self-citationIntravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema
Jonas, J. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.1.57 · Cited by 563
Knopp, R. H., d’Emden, M., Smilde, J. G., Pocock, S. J., & on behalf of the ASPEN Study Group (2006) · Diabetes Care · doi:10.2337/dc05-2415 · Cited by 550
SPAIDE, R. F., & FISHER, Y. L. (2006) · Retina · doi:10.1097/00006982-200603000-00004 · Cited by 507
Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema
Jonas, J. B., & Söfker, A. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01010-8 · Cited by 481
WANG, P. (1993) · The Lancet · doi:10.1016/0140-6736(93)90816-y · Cited by 446
GILLIES, M., SUTTER, F., SIMPSON, J., LARSSON, J., ALI, H., & ZHU, M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.065 · Cited by 425
Self-citationMassin, P., Audren, F., Haouchine, B., Erginay, A., Bergmann, J.-F., Benosman, R., Caulin, C., & Gaudric, A. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.05.037 · Cited by 420
Blood Pressure, Lipids, and Obesity Are Associated With Retinopathy
van Leiden, H. A., Dekker, J. M., Moll, A. C., Nijpels, G., Heine, R. J., Bouter, L. M., Stehouwer, C. D. A., & Polak, B. C. P. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1320 · Cited by 414
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1631 · Cited by 395
Aldington, S. J., Kohner, E. M., Meuer, S., Klein, R., Sj�lie, A. K., & The EURODIAB IDDM Complications Study Group (1995) · Diabetologia · doi:10.1007/bf00410281 · Cited by 384
Dahl-Jørgensen, K., Brinchmann-Hansen, O., Hanssen, K. F., Sandvik, L., & Aagenaes, O. (1985) · BMJ · doi:10.1136/bmj.290.6471.811 · Cited by 360
Effect of Pregnancy on Progression of Diabetic Retinopathy
Klein, B. E. K., Moss, S. E., & Klein, R. (1990) · Diabetes Care · doi:10.2337/diacare.13.1.34 · Cited by 354
REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT
AVERY, R. L. (2006) · Retina · doi:10.1097/00006982-200603000-00016 · Cited by 342
Dahl-Jorgensen, K., Brinchmann-Hansen, O., Hanssen, K. F., Ganes, T., Kierulf, P., Smeland, E., Sandvik, L., & Aagenaes, O. (1986) · BMJ · doi:10.1136/bmj.293.6556.1195 · Cited by 329
Intraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide Injection
JONAS, J., DEGENRING, R., KREISSIG, I., AKKOYUN, I., & KAMPPETER, B. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.10.042 · Cited by 323
Chun, D. W., Heier, J. S., Topping, T. M., Duker, J. S., & Bankert, J. M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.04.033 · Cited by 295
Safety of an Intravitreal Injection of Triamcinolone: Results From a Randomized Clinical Trial
Gillies, M. C. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.3.336 · Cited by 291
Self-citationThe association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes
Klein, R., Sharrett, A. R., Klein, B. E. K., Moss, S. E., Folsom, A. R., Wong, T. Y., Brancati, F. L., Hubbard, L. D., & Couper, D. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01074-6 · Cited by 287
Self-citationPerspectives on diabetic retinopathy
Aiello, L. M. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00219-8 · Cited by 282
Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.032 · Cited by 276
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.4.469 · Cited by 274
Risk Factors for Incident Retinopathy in a Diabetic and Nondiabetic Population: The Hoorn Study
van Leiden, H. A. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.2.245 · Cited by 265
Lauritzen, T., Frost-Larsen, K., Larsen, H.-W., Deckert, T., & The Steno Study Group (1985) · Diabetes · doi:10.2337/diab.34.3.s74 · Cited by 252
Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic Individuals
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.012 · Cited by 244
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Moss, S. E., Klein, B. E. K., Dams, M. D., & DeMets, D. L. (1989) · Ophthalmology · doi:10.1016/s0161-6420(89)32699-6 · Cited by 240
Is Blood Pressure a Predictor of the Incidence or Progression of Diabetic Retinopathy?
Klein, R. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2427 · Cited by 229
REICHARD, P., BERGLUND, B., BRITZ, A., CARS, I., NILSSON, B. Y., & ROSENQVIST, U. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00415.x · Cited by 220
Pars Plana Vitrectomy in the Early Treatment Diabetic Retinopathy Study
Flynn, H. W., Chew, E. Y., Simons, B. D., Barton, F. B., Remaley, N. A., & Ferris, F. L. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31779-8 · Cited by 202
Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia
Sen, K., Misra, A., Kumar, A., & Pandey, R. M. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00341-2 · Cited by 185
Avitabile, T., Longo, A., & Reibaldi, A. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.05.021 · Cited by 161
Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project
McKay, R. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.8.865 · Cited by 161
Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment.
Rohan, T. E., Frost, C. D., & Wald, N. J. (1989) · BMJ · doi:10.1136/bmj.299.6709.1198 · Cited by 160
Reichard, P., Pihl, M., Rosenqvist, U., & Sule, J. (1996) · Diabetologia · doi:10.1007/s001250050602 · Cited by 152
Brinchmann-Hansen, O., Dahl‐Jørgensen, K., Sandvik, L., & Hanssen, K. F. (1992) · BMJ · doi:10.1136/bmj.304.6818.19 · Cited by 152
The Association of Microalbuminuria with Diabetic Retinopathy
Cruickshanks, K. J., Ritter, L. L., Klein, R., & Moss, S. E. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31562-9 · Cited by 147
Pkc-Drs, G. B. (2005) · Clinical Diabetology · Cited by 144
Macular edema--an overlooked complication of diabetic retinopathy.
Pätz, A., Schatz, H., Jw, B., Gittelsohn, A. M., & Ticho, U. (1973) · PubMed · Cited by 133
Kriska, A. M., LaPorte, R. E., Patrick, S. L., Kuller, L. H., & Orchard, T. J. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90153-z · Cited by 123
Vitrectomy for Persistent Diffuse Diabetic Macular Edema
STOLBA, U., Binder, S., Gruber, D., Krebs, I., Aggermann, T., & Neumaier‐Ammerer, B. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.03.045 · Cited by 123
UK Prospective Diabetes Study Group, KOHNER, E. M., STRATTON, I. M., Aldington, S. J., Holman, R. R., & Matthews, D. R. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00458.x · Cited by 121
Intravitreal Avastin: The Low Cost Alternative to Lucentis?
Rosenfeld, P. J. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.03.036 · Cited by 120
Chew, E. Y., Klein, M. L., Murphy, R. P., Remaley, N. A., & Ferris, F. L. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100010054020 · Cited by 120
Vitrectomy in the management of diabetic retinopathy
Smiddy, W. E., & Flynn, H. W. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00036-3 · Cited by 114
Diabetic Macular Edema and Argon Laser Photocoagulation: A Prospective Randomized Study
Blankenship, G. W. (1979) · Ophthalmology · doi:10.1016/s0161-6420(79)35534-8 · Cited by 112
Kang, S. W. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.5.653 · Cited by 110
Bergenstal, R. M., Morse, P. H., Rubenstein, A. H., Jj, B., Bilous, R., Keen, H., Pickup, J. C., Viberti, G. C., Gosh, G., KOHNER, E. M., et al. (1988) · JAMA · Cited by 110
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema: A Prospective, Randomized Study
Jonas, J. B., Kamppeter, B. A., Harder, B., Vossmerbaeumer, U., Sauder, G., & Spandau, U. H. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.200 · Cited by 108
Appropriate Blood Pressure Control in NIDDM (ABCD) Trial
Schrier, R. W., Estacio, R. O., & Jeffers, B. (1996) · Diabetologia · doi:10.1007/s001250050629 · Cited by 102
A 6-year nationwide cohort study of glycaemic control in young people with Type 1 diabetes
Olsen, B. S., Sjolie, A.-K., Hougaard, P., Johannesen, J., Borch‐Johnsen, K., Marinelli, K., Thorsteinsson, B., Pramming, S., & Mortensen, H. B. (2000) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00078-7 · Cited by 102
Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema
Spandau, U. H. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.062596 · Cited by 100
Is Gross Proteinuria a Risk Factor for the Incidence of Proliferative Diaberic Retinopathy?
Klein, R., Moss, S. E., & Klein, B. E. K. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31514-9 · Cited by 99
Growth Hormone and Diabetes mellitus
Sönksen, P. H., Russell-Jones, D. L., & Jones, R. H. (2008) · Hormone Research · doi:10.1159/000183770 · Cited by 99
A Cohort Study of the Relationship of Diabetic Retinopathy to Blood Pressure
Klein, R. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100050069033 · Cited by 95
Association of Cigarette Smoking With Diabetic Retinopathy
Moss, S. E., Klein, R., & Klein, B. E. K. (1991) · Diabetes Care · doi:10.2337/diacare.14.2.119 · Cited by 91
Vitrectomy in the management of diabetic eye disease
Ho, T., Smiddy, W. E., & Flynn, H. W. (1992) · Survey of Ophthalmology · doi:10.1016/0039-6257(92)90137-i · Cited by 88
British Multicentre Study Group (1984) · Diabetologia · doi:10.1007/bf00281116 · Cited by 82
A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema
Thomas, D., Bunce, C., Moorman, C., & Laidlaw, D. A. H. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.044966 · Cited by 73
The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics
The DIRECT Programme Study Group (2005) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2005.003 · Cited by 67
KIRKEGAARD, C., Nørgaard, K., Snorgaard, O., Bek, T., Larsen, M., & Lund‐Andersen, H. (1990) · European Journal of Endocrinology · doi:10.1530/acta.0.1220766 · Cited by 67
ADVANCE Collaborative Group (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01596.x · Cited by 62
Klein, R., Palta, M., Allen, C. B., Shen, G., Han, D. P., & D'Alessio, D. J. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150353007 · Cited by 60
What We Don't Know About Avastin Might Hurt Us
Gillies, M. C. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.10.1478 · Cited by 53
Self-citationDouble-blind trial of Atromid-S in exudative diabetic retinopathy.
Cullen, J. F., Town, S. M., & Cj, C. (1974) · PubMed · Cited by 35
Pituitary ablation for diabetic retinopathy. I. Results of hypophysectomy. (A ten-year evaluation)
Ray, B. S. (1968) · JAMA · doi:10.1001/jama.203.2.79 · Cited by 32
Gardner, T. W., Sander, B., Larsen, M. L., Kunselman, A. R., TenHave, T. R., Lund‐Andersen, H., Reimers, J. L., Hubbard, L. D., Blankenship, G. W., Quillen, D. A., et al. (2006) · Current Eye Research · doi:10.1080/02713680600746112 · Cited by 29
Knudsen, S. T., Bek, T., Poulsen, P. L., Hove, M. N., Rehling, M., & Mogensen, C. E. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01192.x · Cited by 26
Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII)
Olsen, T., Ehlers, N., Richelsen, B., & Beck‐Nielsen, H. (1987) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1987.tb06998.x · Cited by 25
Long‐term effectiveness of modified grid laser photocoagulation for diffuse diabetic macular edema
Ladas, I. D., & THEODOSSIADIS, G. P. (1993) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1993.tb07154.x · Cited by 25
Thomason, M. J., Colhoun, H. M., Livingstone, S. J., Mackness, M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., Neil, H. A. W., Fuller, J., & the CARDS Investigators (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01401.x · Cited by 22
Wang, P. H., Lau, J. T. F., & Chalmers, T. C. (1994) · Retina · doi:10.1097/00006982-199414030-00025 · Cited by 22
Controversies in Intravitreal Triamcinolone Acetonide Use
Sobrin, L., & Amico, D. J. D. (2005) · International Ophthalmology Clinics · doi:10.1097/01.iio.0000176353.56990.3b · Cited by 18
Beck‐Nielsen, H., Olesen, T. B., Mogensen, C. E., Richelsen, B., Olsen, H. W., Ehlers, N., Charles, P., & Sørensen, N. S. (1990) · PubMed · Cited by 16
Egger, M., Davey Smith, G., Stettler, C., & Diem, P. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199711)14:11<919::aid-dia456>3.0.co;2-a
Cited by
Cheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
Self-citationPrevalence and Control of Diabetes in Chinese Adults
Xu, Y. (2013) · JAMA · doi:10.1001/jama.2013.168118 · Cited by 2,703
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569
Self-citationKeech, A., Mitchell, P., Summanen, P., O'Day, J., Davis, T., Moffitt, M., Taskinen, M.-R., Simes, R., Tse, D., Williamson, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61607-9 · Cited by 1,109
Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.12 · Cited by 1,094
Self-citation
Metadata
- Authors
- Mohamed, Q., Gillies, M. C., & Wong, T. Y.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2007-08-22
- Volume
- 298
- Issue
- 8
- Pages
- 902
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2032687008
- Cited by
- 891
- References
- 99
- FWCI
- 32.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.